Ding Z - Search Results

1

A mutation of cysteine 46 in IKK-β promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis.

Zou B, Zhang Y, Li T, Liu J, Deng W, Tan Y, Yang Q, Ding Z, Liao K, Xu J, Pan H, Li X, Liu L. Zou B, et al. Among authors: ding z. Biochem Pharmacol. 2020 Feb;172:113762. doi: 10.1016/j.bcp.2019.113762. Epub 2019 Dec 14. Biochem Pharmacol. 2020. PMID: 31843541

2

IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock.

Tao L, Wang Y, Xu J, Su J, Yang Q, Deng W, Zou B, Tan Y, Ding Z, Li X. Tao L, et al. Among authors: ding z. Pharmacol Res. 2019 Oct;148:104457. doi: 10.1016/j.phrs.2019.104457. Epub 2019 Sep 16. Pharmacol Res. 2019. PMID: 31536782

3

Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Zou BH, Tan YH, Deng WD, Zheng JH, Yang Q, Ke MH, Ding ZB, Li XJ. Zou BH, et al. Acta Pharmacol Sin. 2021 May;42(5):744-754. doi: 10.1038/s41401-020-0477-4. Epub 2020 Aug 4. Acta Pharmacol Sin. 2021. PMID: 32753731 Free PMC article.

4

Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca²⁺-NFATc1 and Cav-1 signaling pathways.

Zou B, Zheng J, Deng W, Tan Y, Jie L, Qu Y, Yang Q, Ke M, Ding Z, Chen Y, Yu Q, Li X. Zou B, et al. Among authors: ding z. Phytomedicine. 2021 Jan;80:153377. doi: 10.1016/j.phymed.2020.153377. Epub 2020 Oct 12. Phytomedicine. 2021. PMID: 33126167

5

Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction.

Deng W, Ding Z, Wang Y, Zou B, Zheng J, Tan Y, Yang Q, Ke M, Chen Y, Wang S, Li X. Deng W, et al. Among authors: ding z. Phytomedicine. 2022 Feb;96:153838. doi: 10.1016/j.phymed.2021.153838. Epub 2021 Nov 6. Phytomedicine. 2022. PMID: 34801352

6

Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.

Yang Q, Guo J, Zheng J, Chen Y, Zou B, Li R, Ding Z, Wang Y, Li L, Chen Z, Mo L, Liang Q, Chen F, Li X. Yang Q, et al. Among authors: ding z. Int Immunopharmacol. 2023 Jul;120:110316. doi: 10.1016/j.intimp.2023.110316. Epub 2023 May 28. Int Immunopharmacol. 2023. PMID: 37253315

7

Inhibition of PPP1R15A alleviates osteoporosis via suppressing RANKL-induced osteoclastogenesis.

Ding ZB, Chen Y, Zheng YR, Wang YY, Deng WD, Zheng JH, Yang Q, Chen ZY, Li LH, Jiang H, Li XJ. Ding ZB, et al. Acta Pharmacol Sin. 2024 Apr;45(4):790-802. doi: 10.1038/s41401-023-01209-0. Epub 2024 Jan 8. Acta Pharmacol Sin. 2024. PMID: 38191913

8

HDAC-targeting epigenetic modulators for cancer immunotherapy.

Cheng B, Pan W, Xiao Y, Ding Z, Zhou Y, Fei X, Liu J, Su Z, Peng X, Chen J. Cheng B, et al. Among authors: ding z. Eur J Med Chem. 2024 Feb 5;265:116129. doi: 10.1016/j.ejmech.2024.116129. Epub 2024 Jan 6. Eur J Med Chem. 2024. PMID: 38211468 Review.

9

Discovery of Novel d-(+)-Biotin-Conjugated Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors for Targeted Cancer Immunotherapy.

Ding Z, Wang S, Shi Y, Fei X, Cheng B, Lu Y, Chen J. Ding Z, et al. J Med Chem. 2023 Aug 10;66(15):10364-10380. doi: 10.1021/acs.jmedchem.3c00479. Epub 2023 Jul 21. J Med Chem. 2023. PMID: 37480153

10

Recent Progress in DNA Damage Response-Targeting PROTAC Degraders.

Cheng B, Fei X, Ding Z, Peng X, Su Z, Pan W, Chen J. Cheng B, et al. Among authors: ding z. J Med Chem. 2024 May 9;67(9):6906-6921. doi: 10.1021/acs.jmedchem.4c00015. Epub 2024 Apr 25. J Med Chem. 2024. PMID: 38663873 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,440 results

Search Page

Filters